The global sustained release coating market is estimated to be valued at US$ 508.2 Mn in 2021 and is expected to exhibit a CAGR of 6.6% over the forecast period (2021-2028).
Figure 1: Global Sustained Release Coating Market Share (%) Analysis, By Polymer Material Type, 2021
Increasing number of product launches by the market players is expected to drive the growth of the global sustained release coating market over the forecast period.
Increasing approvals from the regulatory authorities is expected to drive the growth of the global sustained release coating market over the forecast period. For instance, on March 26, 2021, Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) approved Myrbetriq (mirabegron extended-release tablets) for the treatment of NDO in pediatric patients aged three years and older who weigh 35 kg or more, and Myrbetriq Granules (mirabegron for extended-release oral suspension), indicated for the treatment of NDO in pediatric patients aged 3 years and older.
Sustained Release Coating Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients